• OUR SERVICES
  • ABOUT
  • STORIES & PRESS
  • BLOG
  • FAQ’s
  • CONTACT US
Menu
  • OUR SERVICES
  • ABOUT
  • STORIES & PRESS
  • BLOG
  • FAQ’s
  • CONTACT US
HEB
| EN

 +972-3-309-4421

New Clients
  • OUR SERVICES
  • ABOUT
  • STORIES & PRESS
  • BLOG
  • FAQ’s
  • CONTACT US
Menu
  • OUR SERVICES
  • ABOUT
  • STORIES & PRESS
  • BLOG
  • FAQ’s
  • CONTACT US
HEB
New Clients
HEB
| EN
New Clients
Menu
  • OUR SERVICES
  • ABOUT
  • STORIES & PRESS
  • BLOG
  • FAQ’s
  • CONTACT US

Archives: Coronavirus

Hydroxychloroquine and azithromycin as a treatment of COVID-19 results of an openlabel non-randomized clinical trial

A Trial of Lopinavir – Ritonavir in Adults with Severe COVID19

Ottawa Hospital screening tool to decrease intubation_ventilators _ improve care

Mount Sinai Health System-Treatment Guidelines – COVID-3-17

Interim Guidance for Healthcare Providers during COVID-19 Outbreak

COVID19 MGH treatment guidance

COVID-19 Adult Treatment Algorithm

Boston Meidcal Center Protocol_for treating all PUI

Handbook of COVID-19 Prevention-en Mobile

Staff shortage clinical care translated

← older

Company

  • Home
  • Services
  • About Us
  • Stories & Press
  • FAQ's
  • MedFund
  • Careers
  • Knowledge Base

Blog

Virtual Immune System Roadmap

3 Emerging Technologies in the Treatment of PTSD

Clinical Trials: What, When, and for Whom?

Harnessing Technology to Improve Medical Research

Contact Us

info@medintcare.com

 1-628-227-0024+ :USA

Israel: +972-3-309-4421

Facebook Twitter Linkedin Youtube

150 Menachem Begin Rd.
Tel Aviv, Israel

Copyright © 2019 – All Rights Reserved

Terms of Service | Privacy Policy

“I was lonely with my syndrome, with more questions than answers. Now feeling not alone "

Please note: the full amount of your donation will go to the fund. When you donate, please indicate “Donation for MedInt patients only” in the donation page.

Go to Kav Lachayim's donation site

Apply for financial assistance from MedFund

Please fill out your details and we’ll get back to you as soon as possible

Click to Chat with us!